Pathophysiology and antioxidant status of patients with fibromyalgia

Rheumatology International

Volumn 31, Issue 2, 2011, Pages 149-152

  Iqbal, Riffat ^a   Mughal, M S ^a   Arshad, Najma ^b   Arshad, Muhammad ^c  

^a GC UNIVERSITY   (Pakistan)

^b UNIVERSITY OF THE PUNJAB   (Pakistan)

^c NATIONAL UNIVERSITY OF SCIENCES AND TECHNOLOGY   (Pakistan)

Author keywords

Cerebrospinal fluid; Chronic fatigue syndrome; Fibromyalgia; Hypothalamic pituitary adrenal axis; Reactive nitrogen species; Reactive oxygen species

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CATALASE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NITRITE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SEROTONIN; SUBSTANCE P; SUPEROXIDE DISMUTASE; THYMOQUINONE;

ANTIOXIDANT ACTIVITY; BLACK CUMIN; CHRONIC FATIGUE SYNDROME; FIBROMYALGIA; GENETIC ASSOCIATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOMODULATION; MENTAL DISEASE; NONHUMAN; OXIDATIVE STRESS; PAIN; PATHOPHYSIOLOGY; PLANT SEED; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIOXIDANTS; FATIGUE SYNDROME, CHRONIC; FIBROMYALGIA; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MICE; OXIDATIVE STRESS; PAIN; PITUITARY-ADRENAL SYSTEM; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SUBSTANCE P;

EID: 79954443824     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-010-1470-x     Document Type: Review

References (43)

1. Goldenberg DL (1997) Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome. Curr Opin Rheumatol 9:135-143 doi:10.1097/00002281- 199703000-00010 (Pubitemid 27223232)
2. Wolfe F, Anderson J, Harkness D, Bennett RM, Caro XJ, Goldenberg DL, Russell IJ, Yunus MB (1997) Health status and disease severity in fibromyalgia: results of a six-center longitudinal study. Arthritis Rheum 40:1571-1579. doi:10.1002/art.1780400905 (Pubitemid 27426149)
3. Hudson JI, Goldenberg DL, Pope HG, Keck PE, Schlesinger L (1992) Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 92:363-367. doi:10.1016/0002-9343 (92) 90265-D
4. Houdenhove BV, Luyten P (2006) Stress depression and fibromyalgia. Acta Neurol Belg 149-156
5. Olson J (2004) Mapping genes for fibromyalgia. NIAMS spotlight on research, fibromyalgia: summaries of research. National institute of arthritis and musculoskeletal and skin diseases
6. Griep EN, Boersma JW, De Kloet ER (1993) Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 20:469-474 (Pubitemid 23102470)
7. Crofford LJ, Pillemer SR, Kalogeras KT (1994) Hypothalamic-pituitary- adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 11:1583-1592. doi:10.1002/art.1780371105 (Pubitemid 24345804)
8. Ross R, Jones K, Eldredge D (2004) Clinical and biochemical features of atypical and melancholic depression subtypes in fibromyalgia patients. Program and abstracts of the American College of Rheumatology (ACR) 71st annual meeting
9. Russell IJ, Michalek JE, Vipraio GA, Fletcher EM, Javors MA, Bowden CA (1992) latelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 19:104-109
10. Yunus MB, Dailey JW, Aldag JC, Masi AT, Jobe PC (1992) Plasma tryptophan and other amino acids in primary fibromyalgia. A controlled study. J Rheumatol 19:90-94
11. Larson AA, Giovengo SL, Russell IJ, Michalek JE (2000) Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways. Pain 87:201-211. doi:10.1016/S0304-3959 (00) 00284-0 (Pubitemid 30621452)
12. Vaeroy H, Helle R, Forre O (1998) Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia. New features for diagnosis. Pain 32:21-26. doi:10.1016/0304-3959 (88) 90019-X
13. Rauch SL, Shin LM, Phelps EA (2006) Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research-past, present, and future. Biol Psychiatry 60:376-382. doi:10.1016/j.biopsych.2006.06. 004 (Pubitemid 44215857)
14. Harris RH, Sundgren PC, Pang Y (2007) Variation in glutamate and glutamine levels within the insula are associated with improvements in clinical and experimental pain in fibromyalgia. Program and abstracts of the American College of Rheumatology (ACR) 71st annual meeting. Boston, Massachusetts
15. Buskila D, Neumann L, Vaisberg G, Alkalay D, Wolfe F (1997) Increased rates of fibromyalgia following cervical spine injury. A controlled study of 161 cases of traumatic injury. Arthritis Rheum 40(3):446-452. doi:10.1002/art. 1780400310 (Pubitemid 27123660)
16. Jeschonneck M, Graohmann G, Hein G, Sprott H (2002) Abnormal microcirculation and temperature in skin above tender points in patients with fibromyalgia. Rheumatology 39:917-921. doi:10.1093/rheumatology/39.8.917
17. Lund N, Bengtsson A, Thorborg P (1986) Muscle oxygen tissue pressure in primary fibromyalgia. Scand J Rheumatol 15:165-173. doi:10.3109/ 03009748609102084 (Pubitemid 16048718)
18. Titova DC, Oeser A, Chung CP, et al (2007) Oxidative stress in fibromyalgia: relationship to symptoms. Program and abstracts of the American college of Rheumatology (ACR) 71st annual meeting
19. Bilici M, Efe H, Koroglu MA, Uydu HA, Bekaroglu M, Deger O (2001) Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 64:43-51. doi:10.1016/S0165-0327 (00) 00199-3 (Pubitemid 32268670)
20. Eisinger J, Gandolfo C, Zakarian H, Ayavou T (1997) Reactive oxygen species, antioxidant status and fibromyalgia. J Musculoskeletal Pain 5:5-15. doi:10.1300/J094v05n04-02 (Pubitemid 27508576)
21. Bagis S, Tamer L, Sahin G, Bilgin R, Guler H, Ercan B, Erdogan C (2005) Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder. Rheumatol Int 25:188-190. doi:10.1007/s00296-003-0427-8 (Pubitemid 40576783)
22. Ozgocmen S, Ozyurt H, Sogut S, Akyol O, Ardicoglu O, Yidizhan H (2005) Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns. Rheumatol Int
23. Sendur OF, Turan Y, Tastaban E, Yenisey C, Serter M (2008) Serum antioxidants and nitric oxide levels in fibromyalgia: a controlled study. Rheumatol Int
24. Wu G, Fang YZ, Yang S, Lupton JR, Turner ND (2004) Glutathione metabolism and its implications for health. J Nutr 134(3):489-492 (Pubitemid 38298485)
25. Altindag O, Celik H (2006) Total antioxidant capacity and the severity of the pain in patients with fibromyalgia. Redox Rep 11:131-135. doi:10.1179/135100006X116628 (Pubitemid 44111109)
26. Cipollone JVF, Falasca K, Mezzetti A, Pizzigallo E, Bucciarelli T, Laurentis SD, Affaitati G, Cesare DD, Giamberardino AD (2003) Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci Lett 335:151-154. doi:10.1016/S0304-3940 (02) 01058-3 (Pubitemid 36071622)
27. Richard EH, Kahn K (2007) Current advances in understanding the pathophysiology of Fibromyalgia. American college of Rheumatology. 71st annual meeting
28. Manuel YKB, Moorkens G, Vertommen J, Noé M, Neve J, De Leeuw I (2000) Magnesium status and parameters of the oxidant-antioxidant balance in patients with chronic fatigue: effects of supplementation with magnesium. J Am Coll Nutr 19:374-382 (Pubitemid 30399596)
29. Ozgocmen S, Sogut S, Ardicoglu O, Fadillioglu E, Pekkutucu I, Akyol O (2004) Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis. Rheumatol Int 24:80-83. doi:10.1007/s00296-003-0335-y (Pubitemid 38388749)
30. Jackson MJ, O'Farrell S (1993) Free radicals and muscle damage. Br Med Bull 49(3):630-641 (Pubitemid 23243835)
31. Okumus M, Gokoglu F, Kocaoglu S, Ceceli E, Yorgancioglu ZR (2006) Muscle performance in patients with fibromyalgia. Singapore Med J 47:752-756 (Pubitemid 44378772)
32. Buchwald D, Garrity D (1994) Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. Arch Intern Med 26:2049-2053. doi:10.1001/archinte.154.18.2049 (Pubitemid 24298902)
33. Singh A, Naidu PS, Gupta S, Kulkarni SK (2002) Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome. J Med Food 5(4):211-220. doi:10.1089/10966200 2763003366 (Pubitemid 36331634)
34. Zaidi SM, Al-Qirim TM, Banu N (2005) Effects of antioxidant vitamins on glutathione depletion and lipid peroxidation induced by restraint stress in the rat liver. Drugs R D 6(3):157-165. doi:10.2165/00126839-200506030-00004 (Pubitemid 40994253)
35. Vijayaraghavan R, Suribabu CS, Sekar B, Oommen PK, Kavithalakshmi SN, Madhusudhanan N, Panneerselvam C (2005) Protective role of vitamin e on the oxidative stress in Hansen's disease (Leprosy) patients. Eur J Clin Nutr 59(10):1121-1128. doi:10.1038/sj.ejcn. 1602221 (Pubitemid 41508658)
36. Cao G, Booth SL, Sadowski JA, Prior RL (1998) Increases in human plasma antioxidant capacity after consumption of controlled diets high in fruit and vegetables. Am J Clin Nutr 68:1081-1087 (Pubitemid 28493970)
37. Merchant RE, Carmack CA, Wise CM (2000) Nutritional supplementation with Chlorella pyrenoidosa for patients with fibromyalgia syndrome: a pilot study. Phytother Res 14:167-173. doi:10.1002/(SICI) 1099-1573 (200005) 14:3<167:AID-PTR560>3. 0. CO;2-R (Pubitemid 30326009)
38. Deshpande RA, Adhikary P, Tipnis H (1974) Stored grain pest control agent from Nigella sativa and pogostemon heyneanus. Bull Grain Tech 12:232-234
39. Nair SC, Salomi MJ, Panikkar B, Panikkar KR (1991) Modulatory effects of Crocus sativus and Nigella sativa extracts on cisplatininduced toxicity in mice. Jethenopharm col 31:75-83
40. Badary OA, Taha RA, Gamel el Din AM, Abdel Wahab MH (2002) The in vitro antioxidant and pro-oxidant action of thymoquinone and tert butylhydroquinone. Egypt J Biochem Mol Biol 20:1-16
41. Riaz M, Syed M, Chaudhary FM (1996) Chemistry of the medicinal plants of the genus Nigella. Hamdard Med 39:40-45
42. Hanafy MSM, Hatem ME (1991) Studies on the antimicrobial activity of Nigella sativa seed. J Ethnopharmacol 34:275-278. doi:10.1016/0378-8741 (91) 90047-H
43. Burits M, Bucar F (2000) Antioxidant activity of Nigella sativa essential oil. Phytother Res 14:323-328. doi:10.1002/1099-1573 (200008) 14:5<323:AID-PTR621>3.0. CO;2-Q (Pubitemid 30655515)